Dr. Raye Litten

Title: Acting Division Director, Division of Medications Development (DMD)/Division of Treatment and Recovery Research (DTRR)

Focus Area: medications development, alcohol biomarkers



Email: rlitten@mail.nih.gov

Phone: 301-443-0636

Address: 6700B Rockledge Drive
                Room 1320
                Bethesda, MD 20892-6902


Dr. Raye Litten is the Acting Director of the Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism (NIAAA). Dr. Litten manages the NIAAA medications development program to treat alcohol use disorder (AUD). He oversees the development of medications for AUD that are efficacious and safe by translating neuroscience discoveries into lead compounds and advancing them through drug development pipeline. Finally, he also serves as the Project Officer for the NIAAA NCIG clinical trials program and served as Project Officer on the multi-site Phase 3 clinical trial COMBINE. Dr. Litten is the author of over 110 publications and co-editor of 9 books and journals. 

Please visit PubMed for a listing of Dr. Litten's scientific publications.




                    Division of Medications Development   |   Division of Treatment and Recovery Research